People: Merck & Co Inc (MRK.N)

MRK.N on New York Stock Exchange

59.36USD
12:18pm EDT
Price Change (% chg)

$0.45 (+0.76%)
Prev Close
$58.91
Open
$58.63
Day's High
$59.39
Day's Low
$58.53
Volume
931,871
Avg. Vol
2,665,459
52-wk High
$59.84
52-wk Low
$44.62

Search Stocks

Frazier, Kenneth 

Brief Biography

Mr. Kenneth C. Frazier is Chairman of the Board, President, Chief Executive Officer of Merck & Co., Inc. Mr. Frazier previously served as Executive Vice President and President, Global Human Health of the Company (2009 to 2010) and Merck Sharp & Dohme Corp. (2007 to 2009). Mr. Frazier also served as Executive Vice President and General Counsel (2006 to 2007) of Merck Sharp & Dohme Corp. (formerly known as Merck & Co., Inc.). Director, Exxon Mobil Corporation since 2009 and Pharmaceutical Research and Manufacturers of America (PhRMA) since 2011. Trustee, The Pennsylvania State University and Cornerstone Christian Academy in Philadelphia, PA; Member, Board of Overseers of Weill Cornell Medical College and Graduate School of Medical Sciences, American Academy of Arts and Sciences, Council on Foreign Relations, the Council of the American Law Institute and the American Bar Association.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
3,120,000 -- 5,150,600 13,375,900

Options Compensation

  Quantity Market Value
Exercisable 549,526 59,804.00
Unexercisable 197,341 --
Exercised 42,199 353,074.00
Search Stocks